Opportunities for and Challenges of Conducting Indirect Treatment Comparisons and Meta-Analyses for Vaccines in Post-EU HTA Regulation Era
The dynamic nature of infectious diseases introduces inherent challenges to the design of vaccine clinical trials, which consequently makes vaccine indirect treatment comparisons (ITCs) and meta-analyses (MAs) more challenging compared with regular pharmaceuticals. However, comparisons of efficacy a...
Saved in:
Main Authors: | Charlotte Graham, Erin Barker, Joe Moss, Emily Gregg, Rachael McCool, Nathalie Largeron, Mélanie Trichard, José Bartelt-Hofer, Maribel Tribaldos |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-06-01
|
Series: | Journal of Market Access & Health Policy |
Subjects: | |
Online Access: | https://www.mdpi.com/2001-6689/13/2/31 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Using indirect comparisons in pharmacoeconomic examination
by: Yu. E. Balykina, et al.
Published: (2015-03-01) -
INDIRECT COMPARISONS IN HEALTH TECHNOLOGY ASSESSMENT
by: S. V. Goryajnov, et al.
Published: (2012-04-01) -
COMPARATIVE CHARACTERISTICS OF THE EFFECTIVENESS OF DIRECT AND INDIRECT RESTORATIONS ON TEETH WITH DISCOLORATION
by: I.V. Zhyvotovskyi, et al.
Published: (2019-09-01) -
Evaluation of Bioequivalence of Generic Imatinib Products and Generic Tacrolimus Products Based on Indirect Comparison of the Results of Their Bioequivalence Studies
by: D. V. Goryachev, et al.
Published: (2019-09-01) -
THE POSSIBILITIES AND RESULTS OF INDIRECT COMPARISON OF BIOLOGICAL AGENTS IN ANKYLOSING SPONDYLITIS
by: Sh. F. Erdes
Published: (2016-12-01)